Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options

Curr Top Med Chem. 2020;20(22):1951-1957. doi: 10.2174/156802662022200917110102.
No abstract available

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • Coinfection / drug therapy
  • Coinfection / epidemiology
  • Coinfection / etiology*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / microbiology*
  • Coronavirus Infections / virology
  • Humans
  • Mycoses / complications*
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / microbiology*
  • Pneumonia, Viral / virology
  • SARS-CoV-2

Substances

  • Antifungal Agents